Wembdox Injection contains Doxycycline 100mg, a broad-spectrum tetracycline antibiotic effective against a wide range of bacterial infections. It acts by inhibiting protein synthesis in susceptible bacteria, thereby preventing bacterial growth and replication. Wembdox Injection is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections, and certain tick-borne diseases such as Lyme disease and Rocky Mountain spotted fever. It is also used in the management of malaria prophylaxis and treatment in combination with other antimalarials. The injectable form allows for rapid systemic absorption, making it suitable for patients who cannot tolerate oral administration or require immediate therapeutic levels. Wembdox Injection should be administered under medical supervision, with dosage and duration tailored according to the severity of infection and patient response. Common side effects include gastrointestinal disturbances, photosensitivity, and hypersensitivity reactions. It is contraindicated in patients with known hypersensitivity to tetracyclines, pregnant women, and children under eight years due to risks of tooth discoloration and bone growth inhibition. Caution is advised in patients with hepatic or renal impairment. Proper hydration is recommended to prevent esophageal irritation. Wembdox Injection is a valuable option in the management of various bacterial infections requiring parenteral therapy.